【レポートの概要(一部)】
1. Executive Summary
2. What are Biosimilars?
3. Emergence of Biosimilars
3.1 Role of the Biologics Price Competition and Innovation (BPCI) ACT
3.2 Issue of Data Exclusivity
4. Industry Definition
4.1 Defining Biosimilars
4.2 Specificity of Biosimilars
4.3 Categories of Biologics
4.4 Importance of Biosimilars
4.5 Comparing Biosimilars with Generics
4.6 Branded Product Business Model
5. Overview of the Biopharmaceutical Industry
5.1 Market Profile
5.2 Biopharmaceutical Manufacturing Process
6. Global Biosimilars Market Statistics
6.1 Market Profile
6.2 Market Size
6.3 Market Value of Branded Biologics Facing Patent Expiry
6.4 Operating Margin for Biosimilar Manufacturers
6.5 Investor Concerns regarding Biosimilars
6.6 Commercial Impact of the European Biosimilars Industry
7. Key Success Factors for Biosimilars
7.1 Long Term Strategy
7.2 Developing Competitive Intelligence
7.3 Proper Financial Structure
7.4 Developing Key Biomanufacturing Competencies
7.5 Developing Clinical Capabilities and Regulatory Expertise
7.6 Well Developed Sales and Distribution Channels
8. Factors Impacting the Global Biosimilars Industry
8.1 Growth of the Industry in Developed Countries
8.2 Growth of the Industry in BRIC Countries
8.3 High Cost of Biologics
8.4 Use of Branded Biologics to Increase
8.5 Introduction of Approval Pathways in the US and Japan
8.6 EU’s Draft on Biosimilar Monoclonal Antibody Guidance
8.7 Unfavorable Tendering Procedures
8.8 Problem of Reference Pricing
8.9 Strategy of Biosimilar Companies with Regards to Hospital and Retail Setting
8.10 Issue of Biosimilar Comparability
8.11 Lack of Incentives, Service Agreements and Marketing Costs
8.12 Availability of Second Generation Branded Biologics
8.13 No Automatic Substitution of Branded Biologics
8.14 Cost-containment to Boost Uptake of Biosimilars
8.15 Lack of Proper IP Protection in Emerging Countries
8.16 Ease of Market Entry in BRIC Countries
8.17 Strong Biologic Capabilities in BRIC Countries
8.18 Restricted Market Access for Domestic Players in Emerging Countries
8.19 Problem of Low Purchasing Power in Emerging Markets
9. Biosimilar Market Drivers & Challenges
9.1 Factors Driving Growth of Biosimilars
9.1.1 Need to Lower Healthcare Costs
9.1.2 Lower Development Costs of Biosimilars as compared to New Biologic Drug
9.1.3 Lower Cost of Treatment with Biosimilars
9.1.4 Upcoming Patent Expiries for Blockbuster Biologics
9.1.5 Large Sales of Biologic Drugs
9.1.6 Greater Profitability of Biosimilars as compared to Generic Drugs
9.2 Factors Restraining the Growth of Biosimilars
9.2.1 Lack of Automatic Substitution
9.2.2 High Cost of Development and Manufacturing as compared to Generics
9.2.3 High Entry Barriers to the Biosimilar Industry
9.2.4 Emergence of Second Generation Biologic Drugs
9.2.5 Patent Protection for Biologic Drugs
10. Regulatory Framework
10.1 Regulatory Framework in Europe
10.1.1 EMEA’s Current Position
10.1.2 Bolar Type Provision
10.1.3 Comparability Exercises
10.1.4 Approval Process for Biosimilars
10.2 Regulatory Framework in Japan
10.2.1 Current Position on Biosimilars
10.3 Regulatory Framework in the USA
10.3.1 BPCIA and the Approval Pathway for Biosimilars
10.3.1.1 Role of Biosimilarity and Interchangeability
10.3.1.2 FDA Regulations Biosimilars Approval and Regulation
10.3.1.3 Demonstration on Basis of Data
10.3.1.4 12 Years of Market and Data Exclusivity
10.3.1.5 Resolution to Patent Dispute
10.3.1.6 Notice of Commercial Marketing to Reference Product Sponsor
10.3.1.7 Substitution of Small Molecular Products
10.4 Differences between FDA & the EMEA
10.5 Issues with Momenta
11. Factors Determining Market Entry in the Global Biosimilar Industry
11.1 Long Drawn-out Biosimilar Clinical Development Timeline
11.2 Approval Pathways for Biosimilars
11.3 High Development Costs of Biosimilars
11.3.1 Costs in Developed Markets
11.4 Biosimilars Manufacturing in Developing Countries ? Pros & Cons
11.4.1 Issues with Regulatory Approval
11.4.2 Clinical Trials
11.4.3 Cost of Research & Development
11.4.4 Manufacturing Barriers
11.5 Proving of ‘Biosimilarity’
11.6 Issues with EMA Draft Guidelines for Biosimilar MAb Approval
11.7 Challenges with Patents
11.8 Role of Market Exclusivity for Branded Biologics
11.9 Strategic Partnerships Driving the Industry
11.9.1 Role of M&A Deals
11.9.1.1 Merck & Co.
11.9.1.2 Pfizer
11.10 Lack of Proper Safety Regulations
12. Biosimilar Approval Pathways in the US and Europe
13. Competitive Landscape
13.1 Key Industry Players
13.2 Key Industry Suppliers
13.3 Generic Drug Producers
13.4 Key Investors in the Industry
13.5 Major Stakeholders in the Industry
13.6 Developed versus Emerging Markets
13.7 Biosimilar Launches
13.8 Analysis by Markets
13.8.1 Biosimilars in Australia
13.8.2 Biosimilars in BRIC Countries
13.8.3 Biosimilars in the European Union (France, Germany, Italy, Spain, the UK)
13.8.4 Biosimilars in Japan
13.8.5 Biosimilars in United States
14. Analysis of Major Biosimilars
14.1 Epoetin
14.2 Filgrastim
14.3 Somatropin
15. Upcoming Patent Expiries and Opportunities for Biosimilars
16. Strategies of Big Pharma to Combat Biosimilars
17. Country-wise Biosimilar Market Analysis
17.1 France
17.1.1 Overview of the Healthcare System
17.1.2 Pricing and Reimbursement
17.1.3 Drivers & Challenges for Biosimilars in France
17.2 Germany
17.2.1 Overview of the Healthcare System
17.2.2 Pricing and Reimbursement
17.2.3 Drivers & Challenges for Biosimilars in Germany
17.3 India
17.4 Italy
17.4.1 Overview of the Healthcare System
17.4.2 Pricing and Reimbursement
17.4.3 Drivers & Challenges for Biosimilars in Italy
17.5 Japan
17.6 Spain
17.6.1 Overview of the Healthcare System
17.6.2 Pricing and Reimbursement
17.6.3 Drivers & Challenges for Biosimilars in Spain
17.7 United Kingdom
17.7.1 Overview of the Healthcare System
17.7.2 Pricing and Reimbursement
17.7.3 Drivers & Challenges for Biosimilars in the UK
17.8 United States
18. Major Industry Players
18.1 Dr. Reddy’s Laboratories Limited
18.1.1 Company Overview
18.1.2 Business Segments
18.1.3 Presence in Biosimilars Market
18.1.4 SWOT Analysis
18.2 Hospira Inc
18.2.1 Company Overview
18.2.2 Business Segments
18.2.3 Presence in Biosimilars Market
18.2.4 SWOT Analysis (Brief Analysis)
18.3 Sandoz International
18.3.1 Company Overview
18.3.2 Business Segments
18.3.3 Presence in Biosimilars Market
18.3.4 SWOT Analysis
18.4 STADA Arzneimittel AG
18.4.1 Company Overview
18.4.2 Business Segments
18.4.3 Presence in Biosimilars Market
18.4.4 SWOT Analysis
18.5 Teva Pharmaceutical Industries
18.5.1 Company Overview
18.5.2 Business Segments
18.5.3 Presence in Biosimilars Market
18.5.4 SWOT Analysis
18.6 Watson Pharmaceuticals
18.6.1 Company Overview
18.6.2 Business Segments
18.6.3 Presence in Biosimilars Market
18.6.4 SWOT Analysis
18.7 3SBio Inc.
18.8 Biocon Limited
18.9 Biopartners Gmbh
18.10 Celltrion Inc
18.11 Intas Biopharmaceuticals
18.12 Kyowa Hakko Kirin Co., Ltd.
18.13 Reliance Life Sciences
18.14 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
18.15 Wockhardt
19. Global Biosimilars Market Outlook
19.1 Market Outlook
19.2 Forecast for Biosimilar Sales
19.3 Forecast for US Biosimilars Market
19.4 Forecast for European Biosimilars Market
19.5 Forecast for Japanese Biosimilars Market
19.6 Forecast for Biosimilars
19.6.1 Biosimilars for Monoclonal Antibodies against Cancer
19.6.2 Erythropoietin (EPO) Biosimilars Markets
19.6.3 Human Growth Hormone (hGH) Biosimilars Markets
19.6.4 Granulocyte ? Colony Stimulating Factor (G-CSF) Biosimilars Markets
19.6.5 Insulin and Insulin Analogs Biosimilars
19.6.6 Interferon alfa Biosimilars
19.6.7 Interferon beta Biosimilars
19.6.8 TNF alfa Inhibitor Biosimilars
20. Appendix
21. Glossary
【レポート販売概要】
■ タイトル:世界のバイオシミラー市場■ 英文:Global Biosimilars Industry
■ 発行日:2013年12月
■ 調査会社:Taiyou Research
■ 商品コード:TAYU40206057
■ 調査対象地域:世界
- ハンドヘルド3Dレーザースキャナーの世界市場展望2017-20276According to Stratistics MRC, the Global Handheld 3D Laser Scanner is accounted for $2.30 billion in 2017 and is expected to reach $6.13 billion by 2026 growing at a CAGR of 11.5% during the forecast period. The rising level of eminent control, and check up standards are the key driving factors for the market growth. However, growing price is hindering the market growth. Handheld 3D Laser Scanner …
- Lumenis Ltd.:市場シェア分析Lumenis Ltd. Market Share Analysis Summary GlobalData’s new report, “Lumenis Ltd. Market Share Analysis” provides in-depth information on Lumenis Ltd..’s market position in the refractive surgery . The report also provides data and information on the overall competitive landscape within the refractive surgery . The report is supplemented with global corporate-level profile with information on the …
- 世界の産業ガス市場:アセチレン、酸素、二酸化炭素、窒素、クリプトン、ヘリウム、特殊ガス等About Industrial Gas Industrial gases such as acetylene, oxygen, carbon dioxide, nitrogen, krypton, helium, and specialty gases are used extensively in process industries such as Oil and Gas, Chemicals, Power, Mining, Metals, Pharmaceuticals, Food, Electronics, and Aerospace. Industrial gases have chemical properties such as reactivity, inertness, and coldness, because of which they are used exten …
- 電気自動車(EV)用バッテリーの世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Electric Vehicle (EV) Battery Market 2019-2023 Technavio recognizes the following companies as the key players in the global electric vehicle (EV) battery market: Automotive Energy Supply Corporation, BYD Company Ltd., GS Yuasa International Ltd., LG Chem, Panasonic Corporation, SAMSUNG SDI CO.,LTD. Commenting on the report, an an …
- 顕微鏡下手術器具の世界市場予測(~2024年)“The microsurgical instruments market is projected to grow at a CAGR of 5.2%.”The microsurgical instruments market is projected to reach USD 2.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 5.2%. The increasing prevalence of chronic diseases, lifestyle disorders, and cancer; benefits of microsurgeries over traditional surgeries; and the increasing number of surgeries among the geriat …
- Greeceのニッケル鉱と濃縮物市場:貿易(輸入、輸出)動向This market research report examines the foreign trade of Greece and its perspectives on the global market for Nickel ores and concentrates. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on Nickel ores and concentrates export/import operations in Greece. The 2002-2012 …
- 世界の商用ヘリコプタ市場動向2013-2023:市場のSWOT分析This SWOT analysis of Commercial Helicopter market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Commercial Helicopter Market 2013-2023 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. SDI st …
- 主変圧器の世界市場:タップ付変圧器、タップ切換変圧器、整流器変圧器About Traction Transformer A traction transformer is a major equipment in the electric traction system of trains, which is powered by electricity. It forms the most integral part of the electric traction system and helps in the smooth movement of motors such as locomotives, high-speed trains, and trams. Traction transformer is used to bring down the voltage from the overhead electric line, i.e., 1 …
- 世界の教育部門におけるデジタルバッジ市場2016-2020About the Digital Badges in Education Market A digital badge is an indicator of skills and accomplishment earned in a learning environment. Digital badges are also known as open badges, micro-credentials, and educational badges. These badges display interactive images that are posted on web pages and linked to data such as issuer information, criteria, curriculum, rubric, evidence, expiration date …
- Avalon Oil & Gas, Inc.:石油・ガスの開発・生産動向及びコスト分析- 2012Avalon Oil & Gas, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Avalon Oil & Gas, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- フォグコンピューティングの世界市場分析:ソリューション別、ハードウェア別(ゲートウェイ、ルーター・スイッチ、センサ)、用途別(コネクテッドビークル、スマートグリッド、スマートシティ、コネクテッドヘルスケア、スマート製造)、地域別、セグメント予測、2016 – 2025The global fog computing market is expected to reach USD 617.3 million by 2025, according to a new report by Grand View Research, Inc. The increasing demand from end-use industries is expected to propel the industry growth. Fog computing is an advancement in Internet of Things (IoT) that has shifted data processing out of the cloud into devices. With the growing number of IoT deployments, the amou …
- OLEDディスプレイの世界市場2017-2021About OLED DisplayOLED is a carbon-based diode, which produces light when electricity is passed through the conductors. OLED is a display technology that provides superior picture quality than LCD. The technology used in OLED display primarily consists of passive and active matrix OLED. Technavio’s analysts forecast the global OLED display market to grow at a CAGR of 21.86% during the period 2017- …
- ICT予算及び人員配置動向:エネルギー産業部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? With the economy showing signs of recovery, energy companies are increasing their ICT investments in 2013. Hardware remains a key area of focus for enterprises in this sector, with energy companies increasing the …
- ココア製品の世界市場:製品種類別(ココア豆、ココアバター、ココアパウダー・ケーキ、ココアペースト・リキュール、チョコレート)、用途別(菓子、食品・飲料、化粧品・医薬品)Cocoa is a product derived by processing the cacao seeds obtained from the cacao tree. Cocoa has its origin in Latin America, however, today is cultivated in almost all tropical regions, from West and Central Africa to Asia and Oceania. There are numerous products produced from cocoa seeds such as cocoa liquor, cocoa butter, and cocoa powder. Cocoa powder is predominantly used to manufacture choco …
- 航空機フライトコントロールシステム(操縦装置)の世界市場予測2021The aircraft flight control system market is projected to grow from USD 11.85 Billion in 2016 to USD 16.59 Billion by 2021, at a CAGR of 6.97% from 2016 to 2021. Increasing demand for new aircraft from regional airline companies in Asia-Pacific and the Middle East, procurement of fighter aircraft, and use of unmanned aerial systems in military programs are the key factors driving the demand for ai …